| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/28/2011 | CA2332179C Uses of dna-pk |
| 06/28/2011 | CA2322008C 2'-fluoronucleosides |
| 06/28/2011 | CA2259944C Melanoma associated peptide analogues and vaccines against melanoma |
| 06/28/2011 | CA2190293C Method of cancer treatment by p53 protein control |
| 06/23/2011 | WO2011075725A1 Methods and compositions related to clot-binding compounds |
| 06/23/2011 | WO2011075630A1 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 06/23/2011 | WO2011075628A1 Heterocyclic compounds and their uses |
| 06/23/2011 | WO2011075620A1 Method for treating haematological cancers |
| 06/23/2011 | WO2011075613A1 Azaindole derivatives, their preparation and their therapeutic application |
| 06/23/2011 | WO2011075565A1 SUBSTITUTED AMINOTHIAZOLONE INDAZOLES AS ESTROGEN RELATED RECEPTOR-Aα MODULATORS |
| 06/23/2011 | WO2011075517A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011075515A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011075035A1 A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy |
| 06/23/2011 | WO2011075032A1 Tumour treatment agents and method |
| 06/23/2011 | WO2011074903A2 Pharmaceutical composition containing a3 adenosine receptor agonist |
| 06/23/2011 | WO2011074652A1 Nucleic acid capable of inhibiting expression of hif-2α |
| 06/23/2011 | WO2011074377A1 Composition containing protopanaxatriol and protopanaxadiol |
| 06/23/2011 | WO2011073929A1 6-(2-furyl)-3-methyl-4-oxo-1,5,6,7-tetrahydroindole-2-carboxylate derivatives and uses thereof |
| 06/23/2011 | WO2011073629A2 Cancer diagnosis and treatment |
| 06/23/2011 | WO2011073419A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance |
| 06/23/2011 | WO2011073286A1 Prostate specific membrane antigen inhibitors |
| 06/23/2011 | WO2011073263A1 1, 7 - diazacarbazoles and their use in the treatment of cancer |
| 06/23/2011 | WO2011073211A1 Combretastatin derivatives and uses therefor |
| 06/23/2011 | WO2011073207A1 Use of a neurofilament peptide for the treatment of glioma |
| 06/23/2011 | WO2011073119A1 Mk2 inhibitors |
| 06/23/2011 | WO2011073092A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| 06/23/2011 | WO2011073091A1 3-(indolyl)-or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarzinoma |
| 06/23/2011 | WO2011073054A1 Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs |
| 06/23/2011 | WO2011072875A1 Fusion polypeptides and their use for prevention and treatment of cancer |
| 06/23/2011 | WO2011072791A1 Sphingosine kinase inhibitors |
| 06/23/2011 | WO2011072779A1 Thiazole derivatives for treating diseases such as cancer |
| 06/23/2011 | WO2011072510A1 Passive solid tumor targeting anticancer prodrug and preparation method thereof |
| 06/23/2011 | WO2011072501A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |
| 06/23/2011 | WO2011072496A1 Epothilone compounds, preparation method and use thereof |
| 06/23/2011 | WO2011072487A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/23/2011 | WO2011072482A1 Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
| 06/23/2011 | WO2011072398A1 Local delivery of drugs from self assembled coatings |
| 06/23/2011 | WO2011072394A1 METHOD OF TREATING SCARS AND ß-CATENIN-MEDIATED DISORDERS USING NEFOPAM COMPOUNDS |
| 06/23/2011 | WO2011072355A1 Method for growing autologous dendritic cells, cells obtained by this method, pharmaceutical compositions and use thereof |
| 06/23/2011 | WO2011050994A3 Closthioamides |
| 06/23/2011 | WO2011041599A3 6-methylvitamin d3 analogs and their uses |
| 06/23/2011 | WO2011039368A3 Dll4-binding molecules |
| 06/23/2011 | WO2011031955A3 Optical monitoring of leukemia |
| 06/23/2011 | WO2011028334A3 Synthesis and isolation of dendrimer systems |
| 06/23/2011 | WO2011022508A3 Substituted benzoazepines as toll-like receptor modulators |
| 06/23/2011 | WO2011020090A3 Compositions and methods for treating cancer |
| 06/23/2011 | WO2011020033A3 Engineered proteins including mutant fibronectin domains |
| 06/23/2011 | WO2011017456A3 Localized delivery of nanoparticles for therapeutic and diagnostic applications |
| 06/23/2011 | WO2011014863A3 Prophylaxis against cancer metastasis |
| 06/23/2011 | US20110154522 BH3 Peptides And Method Of Use Thereof |
| 06/23/2011 | US20110152768 Treatment of Solid Tumors with Tissue Inhibitors of Metalloproteinases (TIMPS) |
| 06/23/2011 | US20110152766 Implant with coating |
| 06/23/2011 | US20110152360 Liquid pharmaceutical formulations of docetaxel |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152358 Compositions and Methods for Diagnosis and Treatment of Pancreatic Ductal Cancer |
| 06/23/2011 | US20110152357 Micro-RNA-Based Compositions and Methods for the Diagnosis, Prognosis and Treatment of Multiple Myeloma |
| 06/23/2011 | US20110152354 Bispecific Oligonucleotide for the Treatment of CNS Malignancies |
| 06/23/2011 | US20110152352 Smad proteins control drosha-mediated mirna maturation |
| 06/23/2011 | US20110152350 Compositions and Methods for Inhibiting Expression of XBP-1 Gene |
| 06/23/2011 | US20110152348 Methods for treating androgen receptor dependent disorders including cancers |
| 06/23/2011 | US20110152346 Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids |
| 06/23/2011 | US20110152345 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 06/23/2011 | US20110152341 Cleavage of b-amyloid precursor protein |
| 06/23/2011 | US20110152339 Fluorescent regulators of rassf1a expression and human cancer cell proliferation |
| 06/23/2011 | US20110152336 Combination therapy with parp inhibitors |
| 06/23/2011 | US20110152331 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152330 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 06/23/2011 | US20110152329 Use of Epothilone Derivatives for the Treatment of Hyperparathyroidism |
| 06/23/2011 | US20110152325 Carboxamide compounds and their use as calpain inhibitors iv |
| 06/23/2011 | US20110152323 Histone deacetylase inhibitors and uses thereof |
| 06/23/2011 | US20110152320 Pyrrole derivatives, their preparation and their therapeutic application |
| 06/23/2011 | US20110152315 Compounds for the treatment of metabolic diseases |
| 06/23/2011 | US20110152313 Synthesis of ageladine a and analogs thereof |
| 06/23/2011 | US20110152310 Tricyclic triazole compounds that modulate hsp90 activity |
| 06/23/2011 | US20110152305 Films and particles |
| 06/23/2011 | US20110152297 Quinazoline derivatives as tyrosine kinase inhibitors |
| 06/23/2011 | US20110152296 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152292 Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use |
| 06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 06/23/2011 | US20110152289 Dimeric derivatives of artemisinin and application in anti-cancer therapy |
| 06/23/2011 | US20110152282 Hedgehog pathway modulators |
| 06/23/2011 | US20110152281 Compounds and method for treatment of cancer |
| 06/23/2011 | US20110152278 Synthesis and anti-proliferative effect of benzimidazole derivatives |
| 06/23/2011 | US20110152277 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152276 Substituted pyrrolo[2,3-d]pyrimidines as antifolates |
| 06/23/2011 | US20110152273 Fused heteroaromatic pyrrolidinones |
| 06/23/2011 | US20110152267 Compositions and Methods for Treating Hyperproliferative Disorders |
| 06/23/2011 | US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 06/23/2011 | US20110152259 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 06/23/2011 | US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 06/23/2011 | US20110152252 Shiga toxin b-subunit/chemotherapeutics conjugates |
| 06/23/2011 | US20110152244 Pyrrolopyrimidine compounds and their uses |
| 06/23/2011 | US20110152243 Novel thienopyrrole compounds |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152240 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152235 Aminopyrimidine Kinase Inhibitors |
| 06/23/2011 | US20110152234 Novel Compounds |
| 06/23/2011 | US20110152230 Photoactive Metal Nitrosyls For Blood Pressure Regulation And Cancer Therapy |